News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Georges Gebrael: RWD of Cabozantinib and ICI vs. cabozantinib monotherapy align with CONTACT03 trial results
Photo taken from Georges Gebrael/X
Apr 4, 2024, 20:02

Georges Gebrael: RWD of Cabozantinib and ICI vs. cabozantinib monotherapy align with CONTACT03 trial results

Georges Gebrael, Research Fellow at Huntsman Cancer Institute and University of Utah, shared on X/Twitter:

“Just in ACS Journal Cancer. Patients with clear cell mRCC kidney cancer from real world Flatiron database status post ICI treatment, similar survival with cabozantinib and ICI vs. cabozantinib monoRx aligning with CONTACT03 trial results.”

Georges Gebrael: RWD of Cabozantinib and ICI vs. cabozantinib monotherapy align with CONTACT03 trial results Georges Gebrael: RWD of Cabozantinib and ICI vs. cabozantinib monotherapy align with CONTACT03 trial results

Source: Georges Gebrael/X

 

ACS Journal Cancer Cabozantinib cancer CONTACT03 trial Georges Gebrael ICI ICI treatment kidney cancer OncoDaily Oncology patients
Special Coverage
Celebrities
Feb 22, 2025, 11:40
Remembering Saxophonist James Casey: His Battle with Colon Cancer and Advocacy
Career
Feb 22, 2025, 11:36
Joseph H. Antin Received ASTCT Lifetime Achievement Award at 2025 Tandem Meetings
Science
Feb 22, 2025, 11:28
Myeloma Paper of the Day, February 22nd, suggested by Robert Orlowski
Blog
Feb 22, 2025, 11:22
Yan Leyfman: Great experience speaking at the NSHSS Pre-Medicine Workshop
Insight
Feb 22, 2025, 11:15
Henrik Ullum: The urgent need to protect WHO is also an opportunity
Oncolibrary
Feb 22, 2025, 11:02
New Paper Alert: Efficacy of Zenocutuzumab in NRG1 Fusion–Positive Cancer
Blog
Feb 22, 2025, 10:57
Tsetsegsaikhan Batmunkh: Factsheets for parents on childhood cancers and essential medicines in the Mongolian
Blog
Feb 22, 2025, 10:47
Akhilesh Bind: Advancing political leadership for equitable cancer care
Blog
Feb 22, 2025, 10:41
Nominations close for the 2025 Szent-Györgyi Prize for Progress in Cancer Research - NFCR
Blog
Feb 22, 2025, 06:28
Michael Sapienza: Breaking the stigma associated with CRC screening with Lead From Behind
Blog
Feb 22, 2025, 05:23
Sanam Loghavi: Excited to see the draft agenda for the inaugural Women in Hematology meeting
Blog
Feb 22, 2025, 05:18
Francisco J. Esteva: The clinical applications of PARPi across various cancers